Verano Holdings Corp
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRNO research report →
Price Chart
About the company
Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis.
- CEO
- George Archos
- IPO
- 2021
- Employees
- 3,800
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on VRNO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $387.33M
- P/E
- -1.48
- Fwd P/E
- 196.50
- PEG
- -0.06
- P/S
- 0.46
- P/B
- 0.57
- EV/EBITDA
- 4.74
- Div Yield
- 0.00%
- Gross Margin
- 46.06%
- Op Margin
- 6.49%
- Net Margin
- -30.92%
- ROE
- -35.22%
- ROIC
- 4.57%
Latest fiscal year · YoY change
- Revenue
- $835.88M-4.9%
- Gross Profit
- $400.59M-9.8%
- Op Income
- $77.51M
- Net Income
- $-262,422,817+23.2%
- EPS
- $-3.60+24.2%
- OCF Growth
- -52.1%
- FCF Growth
- -10.0%
- 52W High
- $9.75
- 52W Low
- $3.91
- 50D MA
- $5.80
- 200D MA
- $5.91
- Beta
- 1.42
- RSI (14)
- 32
- Avg Volume
- 116.18K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Verano said second-quarter results were pressured by purposeful wholesale pullbacks and competition, but margins improved and management expects a stronger back half of 2025 with gradual wholesale recovery.· August 7, 2025
- Q2 revenue was $202 million, down 4% sequentially and 9% year over year, while adjusted EBITDA was $66 million, or 33% of revenue.
- Gross profit was $113 million with gross margin of 56%, helped by cultivation/production efficiencies and lower wholesale mix.
- Retail revenue was $169 million, up 3% year over year; wholesale revenue was $73 million, down 8% sequentially and 21% year over year excluding intersegment eliminations.
- Management said its accounts receivable strategy intentionally reduced wholesale sales, but it is now seeing accounts “turn back on slowly” and expects a modest wholesale improvement in the second half.
- Full-year CapEx is still expected at $30 million to $45 million, and management expects to maintain a historical 30% adjusted EBITDA margin profile in the back half of the year.
Second-quarter revenue was $202 million, down 4% sequentially and 9% year over year. Gross profit was $113 million, or 56% of revenue, flat year over year but up 13% sequentially. Adjusted EBITDA was $66 million, or 33% of revenue, down 6% year over year and up 7% sequentially. Retail revenue was $169 million, up 3% year over year and flat sequentially; wholesale revenue was $73 million, down 8% sequentially and 21% year over year, excluding intersegment eliminations. SG&A was $86 million versus $87 million a year ago. The company ended the quarter with $69 million in cash and cash equivalents, generated $11 million of cash from operations, spent $10 million on CapEx, and expects full-year 2025 CapEx of $30 million to $45 million. Management expects the back half of 2025 to reflect a more historical 30% adjusted EBITDA margin profile, modest improvement in wholesale, and higher cash balances in Q3 and Q4.
George Archos framed the quarter as progress on strengthening the business for a better second half, emphasizing efficiencies, product innovation, automation and differentiation. He said the company deliberately reduced wholesale sales to rationalize the business and collect receivables, and now sees accounts gradually reopening in a “slow ramp up” that should continue into 2026. He also highlighted new product launches, dispensary openings, and optimism tied to Florida, Virginia, Pennsylvania, and rescheduling.
Rich Tarapchak focused on margin expansion, cost discipline and balance-sheet management. He said gross profit reached $113 million, gross margin was 56%, SG&A was $86 million, adjusted EBITDA was $66 million, and the company reduced net outstanding receivables by about $9 million year to date; he also cited $16 million of debt payments, including an early prepayment on the Cannabist-related loan at 75% of face value, saving about $4 million. He added that cash should bottom in the second quarter, with higher cash balances expected in Q3 and Q4, and that Verano is in proactive refinancing discussions ahead of the October 2026 term-loan maturity.
Analysts focused on wholesale stabilization, gross margin durability, Pennsylvania adult-use prospects, Virginia growth, cash use, and refinancing. Management said wholesale will not rebound sharply because it is intentionally turning accounts back on slowly and only as customers can pay, but it expects a modest back-half improvement as receivables are resolved and new products launch. On margins, management said the 56% gross margin reflected efficiencies in Florida and Illinois and should revert to a more historical 30% adjusted EBITDA margin profile in the second half; on refinancing, management said it feels confident, citing its real estate ownership as a potential support.
The bullish case is that the quarter showed better execution on profitability even as revenue fell, with gross margin at 56% and adjusted EBITDA margin at 33%. Management is also pointing to a pipeline of new products, improving accounts receivable trends, and possible catalysts in Virginia, Pennsylvania and Florida that could support the back half of the year.
The bear case is that revenue is still declining, wholesale remains under pressure from deliberate pullbacks plus competition and price compression, and management does not expect a fast rebound. Cash was reduced by taxes and debt paydown, wholesale recovery is expected to be slow, and some key markets such as Illinois and New Jersey remain challenged by new store openings and continued retail pressure.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.8%
- Shares Outstanding
- 73.92M
- Float Shares
- 65.65M
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 2 ETFs
Biggest fund positions in VRNO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 8, 26 | Heine Josh | other | 163 |
| Sep 8, 26 | Heine Josh | other | 163 |
| Sep 8, 26 | Heine Josh | other | 48 |
| Jun 9, 26 | Spreckman David | other | 150,000 |
| Jun 9, 26 | Spreckman David | other | 43,950 |
| Jun 9, 26 | McDermott Edward Aloysious III | other | 300,000 |
| Jun 9, 26 | McDermott Edward Aloysious III | other | 86,250 |
| Jun 9, 26 | Kalesnik Laura Marie | other | 250,000 |
| Jun 9, 26 | Kalesnik Laura Marie | other | 60,875 |
| Jun 9, 26 | Tarapchak Richard C | other | 300,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VRNO coverage
Recent articles, reports, and earnings notes.
No research on VRNO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VRNO report →Verano to Report Third Quarter 2026 Financial Results on October 29, 2026
globenewswire.com · Sep 23
Verano Announces Upcoming Conference Participation
globenewswire.com · Sep 2
Looking for Marijuana Stocks? 3 Cannabis Companies to Watch in August 2026
marijuanastocks.com · Aug 25
Verano Enters Cannabis Beverage Category with Debut of Easy Landings, Company's First National Beverage Brand Featuring Four Delicious Flavors and All-Natural Ingredients
globenewswire.com · Aug 20
Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.
fool.com · Aug 6
Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue
globenewswire.com · Aug 5
Best Marijuana Stocks to Add to Your August 2026 Watchlist
marijuanastocks.com · Jul 30
Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company's Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide
globenewswire.com · Jul 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.